(Q53241134)

12 May 2018

title

Anti-inflammatory therapy for Alzheimer's disease: implications of the prednisone trial. (English)

1 reference

12 May 2018

1 reference

P S Aisen

1

1 reference

12 May 2018

publication date

1 January 2000

1 reference

12 May 2018

Acta neurologica Scandinavica. Supplementum

published in

1 reference

12 May 2018

volume

176

1 reference

12 May 2018

page(s)

85-89

1 reference

12 May 2018

Inflammation and Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Anti-inflammatory drugs and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Cortisol levels during human aging predict hippocampal atrophy and memory deficits.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

New insights into the mode of action of anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Cyclooxygenases and the Central Nervous System

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Development of a disease-modifying treatment for Alzheimer's disease: Alzhemed

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Etanercept: a review of its use in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00312.X

7 January 2021

10.1034/J.1600-0404.2000.00312.X

Identifiers

DOI

0 references

1 reference

12 May 2018